Tissue Eng Regen Med.  2017 Dec;14(6):653-665. 10.1007/s13770-017-0093-7.

Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases

Affiliations
  • 1Laboratory of Stem Cells, NEXEL Co., Ltd., 9th Floor, 21 Wangsan-ro, Dongdaemun-gu, Seoul 02580, Korea.
  • 2Department of Neurosurgery, Korea University Medical Center, Anam Hospital, Korea University College of Medicine, 73 Inchonro, Sungbuk-gu, Seoul 02841, Korea.
  • 3Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University, #101 Daehak-ro, Jongro-gu, Seoul 03080, Korea.
  • 4Laboratory of Stem Cells and Tissue Regeneration, Department of Biotechnology, College of Life Sciences and Biotechnology, Science Campus, Korea University, 145 Anam-ro, Seongbu-gu, Seoul 02841, Korea. jhkim@korea.ac.kr

Abstract

Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.

Keyword

Liver failure; Liver regeneration; Stem cell transplantation; Secretome

MeSH Terms

Bone Marrow Cells
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cells
Hepatocytes
Humans
Inflammation
Liver Cirrhosis
Liver Diseases*
Liver Failure
Liver Regeneration
Liver Transplantation
Liver*
Macrophages
Mesenchymal Stromal Cells
Stem Cell Transplantation
Stem Cells*
Tissue Donors
Full Text Links
  • TERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr